How I Avoided a Hysterectomy : A 95% Fibroid Reduction in 5 months. Case Study with AHCC and DIM
Beyond the Scalpel: How I Achieved a 95% Reduction in Fibroid Mass Without Surgery
A personal case study in systems biology, immune modulation, and nervous-system repair
By Catalina Guirado
Disclaimer: This article reflects my personal experience and interpretation of existing scientific literature. It is shared for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making medical or supplement decisions.
When Grief Becomes Biology
After a period of profound personal loss—losing both my mother and my best friend within a single year—my body reached a breaking point.
By mid-2025, I experienced a 58-day hemorrhaging episode that led to emergency imaging and a diagnosis of large, symptomatic uterine fibroids. Surgery was presented as the likely next step. But as a health professional, I understood something critical:
Fibroids are not random growths—they are biologically driven, hormonally responsive, and deeply influenced by immune and metabolic signaling.
I believed that if I could address the immune and hormonal drivers simultaneously, rather than suppress symptoms, my body might be able to restore balance. What followed surprised both my doctor and me. Within five months, follow-up imaging showed an approximately 95% reduction in fibroid volume, without surgery, embolization, or hormone suppression.
I refer to the central mechanism behind this outcome as the “Magic Pincer” effect—the synergistic use of AHCC (Active Hexose Correlated Compound) and DIM (Diindolylmethane), layered onto a foundation of metabolic and nervous-system regulation.
The Science of the “Magic Pincer”
Fibroids thrive in a "perfect storm" of two conditions:
Hormonal dominance (the fuel)
Immune dysfunction (failure to clear abnormal tissue)
Addressing only one allows the other to continue driving growth. Shrinkage requires both to be addressed simultaneously.
1. The Immune Effector: AHCC (Kinoko Gold)
AHCC is most commonly discussed in the context of HPV and oncology, but its role in immune-mediated tissue remodeling is the "missing link" in fibroid regression.
Macrophage Polarization: Fibroids exist in a pro-inflammatory microenvironment where macrophages become locked in a growth-supporting (M2) state. AHCC promotes a shift toward an anti-inflammatory, reparative macrophage phenotype.
Natural Killer (NK) Cell Activation: Fibroids often evade immune surveillance. AHCC significantly increases NK-cell and T-cell activity—the "cleanup crew" responsible for identifying and clearing abnormal tissue.
+1
STAT3 Signaling Inhibition: The STAT3 pathway is a known driver of cellular proliferation and fibrosis. AHCC has demonstrated the ability to down-regulate STAT3 signaling, halting growth momentum at the cellular level.
+1
2. The Hormonal Regulator: DIM (Diindolylmethane)
If AHCC is the demolition crew, DIM is the valve that shuts off the fuel supply.
The 2:16 Pathway Shift: Fibroids are highly estrogen-sensitive. DIM does not suppress estrogen; it alters how it is metabolized—favoring the protective 2-hydroxyestrone pathway over the proliferative 16-hydroxyestrone pathway.
Induction of Apoptosis: Research demonstrates that DIM can induce apoptosis (programmed cell death) in uterine leiomyoma cells while sparing healthy tissue.
The Triple-Threat Foundation: Fuel, Signal, and Cleanup
The “pincer” only works when the underlying metabolic terrain is addressed. My protocol attacked the pathology from three distinct angles:
I. Metabolic Control: Berberine & Myo-Inositol
Fibroids are insulin-sensitive. Elevated insulin and IGF-1 act as growth accelerants. By using Berberine (an AMPK activator) and Myo-Inositol, I improved insulin sensitivity and effectively "starved" the fibroid of its growth fuel.
Outcome: Insulin resistance score dropped from 83 → A1c stabilized at 5.3%, fasting glucose 78.
II. Hormonal Signal Neutralization: DIM
This shift ended the 58-day hemorrhaging episode by removing the proliferative signal of aggressive estrogen metabolites.
III. Active Tissue Clearance: AHCC
Once insulin and estrogen signaling were neutralized, AHCC enabled the immune system to physically debride and reabsorb the fibrotic mass.
Clinical Data (Aug 2025 → Jan 2026)
Aug 19, 2025 (Initial) Jan 13, 2026 RESULTS
OutcomePosterior Fibroid : 4.4 × 4.1 × 4.6 cm 1.2 × 0.8 × 1.0 cm ~ 95% Vol. Reduction
Anterior Fibroid : 4.1 × 3.5 × 4.2 cm 0.7 × 0.6 × 0.9 cm - Near Resolution
Ovarian Cysts : 2 (3.2 cm & 2.4 cm) 1 (1.8 cm) - 50% Resolution
Hemorrhaging : 58-Day Continuous Resolved.
Metabolic State: IR Score: 83 A1c 5.3 / Glucose 78 - Reversed
Trauma, Stress & Fibroid Biology
Chronic grief elevates cortisol, which disrupts immune surveillance and impairs the liver's ability to clear hormones. This protocol worked because it was paired with nervous-system repair—including yoga, meditation, art therapy, and periods of deep parasympathetic restoration. Healing required safety, not force.
Conclusion: A Non-Surgical Possibility
This is not a universal prescription; it is one documented case. However, it demonstrates what becomes possible when immune function, hormone metabolism, insulin signaling, and nervous-system regulation are addressed together.